Andrew Alexander Somogyi (Andrew A Somogyi)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Advanced Cancer

Papillary Thyroid

Top Venues

The pharmacogenomics journal

Journal of palliative medicine

British journal of clinical pharmacology

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Thomas Barratt, Pål Klepstad, Ola Dale, Stein Kaasa, Andrew Alexander Somogyi
Pharmacokinetic and neuroimmune pharmacogenetic impacts on slow-release morphine cancer pain control and adverse effects. The pharmacogenomics journal 24 (3) (2024)
Daniel Thomas Barratt, Pål Klepstad, Ola Dale, Stein Kaasa, Andrew Alexander Somogyi
Pharmacokinetic and neuroimmune pharmacogenetic impacts on slow-release morphine cancer pain control and adverse effects. The pharmacogenomics journal 24 (3) (2024)
Katherine M Robinson, Seenae Eum, Zeruesenay Desta, Rachel Fynvola Tyndale, Andrea Gaedigk, Richard C Crist, Cyrine E Haidar, Alan L Myers, Caroline Flora Samer, Andrew Alexander Somogyi, Pablo Zubiaur, Otito F Iwuchukwu, Michelle Whirl-Carrillo, Teri E Klein, Kelly E Caudle, Roseann S Donnelly, Evan D Kharasch
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy. Clinical pharmacology and therapeutics (2024)
Daniel Thomas Barratt, Pål Klepstad, Ola Dale, Stein Kaasa, Andrew Alexander Somogyi
Pharmacokinetic and neuroimmune pharmacogenetic impacts on slow-release morphine cancer pain control and adverse effects. The pharmacogenomics journal 24 (3) (2024)
Daniel Thomas Barratt, Pål Klepstad, Ola Dale, Stein Kaasa, Andrew Alexander Somogyi
Pharmacokinetic and neuroimmune pharmacogenetic impacts on slow-release morphine cancer pain control and adverse effects. The pharmacogenomics journal 24 (3) (2024)
Aaron Kee Yee Wong, Andrew Alexander Somogyi, Justin Rubio, Tien Dung Pham, Brian H Le, Pal Klepstad, Jennifer Philip
Effectiveness of Opioid Switching in Advanced Cancer Pain: A Prospective Observational Cohort Study. Cancers 15 (14) (2023)
Andrew J Toner, Martin A Bailey, Stephan A Schug, Michael Phillips, Jacobus Pj Ungerer, Andrew Alexander Somogyi, Tomas B Corcoran
Serum lidocaine (lignocaine) concentrations during prolonged perioperative infusion in patients undergoing breast cancer surgery: A secondary analysis of a randomised controlled trial. Anaesthesia and intensive care (2023)
Aaron Kee Yee Wong, Pål Klepstad, Andrew Alexander Somogyi, Sara Vogrin, Brian H Le, Jennifer A M Philip, Justin P Rubio
Effect of gene variants on opioid dose, pain and adverse effect outcomes in advanced cancer: an explorative study. Pharmacogenomics (2023)
Jennifer A M Philip, Aaron Kee Yee Wong, Leeanne Pasanen, Andrew Alexander Somogyi, Justin P Rubio, Pål Klepstad, Anna Collins, Peter Gibbs, Brian H Le
Establishing a Longitudinal Opioid Pharmacogenomic Registry for Cancer Patients: Feasibility and Acceptability. Journal of palliative medicine 26 (3) (2022)
Andrew Alexander Somogyi, Stefan T Musolino, Daniel Thomas Barratt
New pharmacological perspectives and therapeutic options for opioids: Differences matter. Anaesthesia and intensive care 50 (1-2) (2022)
Jennifer A M Philip, Aaron Kee Yee Wong, Leeanne Pasanen, Andrew Alexander Somogyi, Justin P Rubio, Pål Klepstad, Anna Collins, Peter Gibbs, Brian H Le
Establishing a Longitudinal Opioid Pharmacogenomic Registry for Cancer Patients: Feasibility and Acceptability. Journal of palliative medicine (2022)
Roseann S Donnelly, Munir Pirmohamed, Andrew Alexander Somogyi, Sarah A Morris, Christine M Formea, Amanda L Elchynski, Kazeem A Oshikoya, Howard L McLeod, Cyrine E Haidar, Michelle Whirl-Carrillo, Teri E Klein, Kelly E Caudle, Mary V Relling
Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype. Clinical pharmacology and therapeutics (2022)
Ahmad Y Abuhelwa, Andrew Alexander Somogyi, Colleen K Loo, Paul Glue, Daniel T Barratt, David J R Foster
Population Pharmacokinetics and Pharmacodynamics of the Therapeutic and Adverse Effects of Ketamine in Patients With Treatment-Refractory Depression. Clinical pharmacology and therapeutics 112 (3) (2022)
Jennifer A M Philip, Aaron Kee Yee Wong, Leeanne Pasanen, Andrew Alexander Somogyi, Justin P Rubio, Pål Klepstad, Anna Collins, Peter Gibbs, Brian H Le
Establishing a Longitudinal Opioid Pharmacogenomic Registry for Cancer Patients: Feasibility and Acceptability. Journal of palliative medicine 26 (3) (2022)
Jennifer A M Philip, Aaron Kee Yee Wong, Leeanne Pasanen, Andrew Alexander Somogyi, Justin P Rubio, Pål Klepstad, Anna Collins, Peter Gibbs, Brian H Le
Establishing a Longitudinal Opioid Pharmacogenomic Registry for Cancer Patients: Feasibility and Acceptability. Journal of palliative medicine 26 (3) (2022)
Daniel T Barratt, Alex T Sia, Ene-Choo Tan, Andrew Alexander Somogyi
Innate Immune and Neuronal Genetic Markers Are Highly Predictive of Postoperative Pain and Morphine Patient-Controlled Analgesia Requirements in Indian but Not Chinese or Malay Hysterectomy Patients. Pain medicine (Malden, Mass.) 22 (11) (2022)
Benedetta C Sallustio, Benjamin D Noll, Rong Hu, Daniel T Barratt, Jonathan Tuke, Janet K Coller, Graeme R Russ, Andrew Alexander Somogyi
Tacrolimus dose, blood concentrations and acute nephrotoxicity, but not CYP3A5/ABCB1 genetics, are associated with allograft tacrolimus concentrations in renal transplant recipients. British journal of clinical pharmacology 87 (10) (2021)
Natália Bordin Andriguetti, Helena Katherina Van Schalkwyk, Daniel Thomas Barratt, Joseph Tucci, Paul Pumuye, Andrew Alexander Somogyi
Large variability in plasma efavirenz concentration in Papua New Guinea HIV/AIDS patients associated with high frequency of CYP2B6 516T allele. Clinical and translational science 14 (6) (2021)
Guilherme Suarez-Kurtz, Eleni Aklillu, Yoshiro Saito, Andrew Alexander Somogyi
Conference report: pharmacogenomics in special populations at WCP2018. British journal of clinical pharmacology 85 (3) (2019)
Andrew Alexander Somogyi, Daniel Thomas Barratt, Elizabeth J Phillips, Kylies Moore, Fahmida Ilyas, Genevieve M Gabb
High and variable population prevalence of HLA-B*56:02 in indigenous Australians and relation to phenytoin-associated drug reaction with eosinophilia and systemic symptoms. British journal of clinical pharmacology 85 (9) (2019)